Lewis, Gail D.
Li, Guangmin
Guo, Jun
Yu, Shang-Fan
Fields, Carter T.
Lee, Genee
Zhang, Donglu
Dragovich, Peter S.
Pillow, Thomas
Wei, BinQing
Sadowsky, Jack
Leipold, Douglas http://orcid.org/0000-0003-2116-4277
Wilson, Tim
Kamath, Amrita
Mamounas, Michael
Lee, M. Violet
Saad, Ola http://orcid.org/0000-0002-2607-8901
Choeurng, Voleak
Ungewickell, Alexander
Monemi, Sharareh
Crocker, Lisa
Kalinsky, Kevin
Modi, Shanu
Jung, Kyung Hae
Hamilton, Erika http://orcid.org/0000-0002-1911-0336
LoRusso, Patricia http://orcid.org/0000-0001-7144-036X
Krop, Ian
Schutten, Melissa M.
Commerford, Renee
Sliwkowski, Mark X.
Cho, Eunpi
Article History
Received: 3 December 2022
Accepted: 14 December 2023
First Online: 11 January 2024
Competing interests
: G.D.L., G.L., J.G., S.-F.Y., C.T.F., G.L., D.Z., P.S.D., T.P., B.W., D.L., A.K., T.W., M.V.L., O.S., V.C., A.U., S.M., L.C. and E.C. are full-time employees of Genentech and shareholders in F. Hoffman-La Roche, Ltd. Jack Sadowsky is a former employee of Genentech, a shareholder in F. Hoffmann-La Roche, Ltd., and an employee of Carmot Therapeutics. Michael Mamounas is a former employee of Genentech and shareholder in F. Hoffmann-La Roche Ltd. K.K. is an advisor and consultant for Eli Lilly, Pfizer, Novartis, Astra Zeneca, Daiichi Sankyo, Puma, 4D Pharma, Oncosec, Immunomedics, Merck, Seagen, Mersana, Menarini Silicon Biosystems, Myovant and Takeda; and receives institutional research funding from Genentech/Roche, Novartis, Eli Lilly, AstraZeneca, Daiichi Sankyo, and Ascentage. S.M. is an advisor and consultant for Genentech, AstraZeneca, Daiichi Sankyo, Macrogenics, Gilead and Seagen; and receives institutional research funding from Genentech, Astra Zeneca, Daiichi Sankyo and Seagen. K.H.J. is an advisor and consultant for AstraZeneca, Bixink, Novartis, Roche, MSD, Pfizer, Everest Medicine, Daiichi Sankyo, Eisai, and Takeda. E.H. is an advisor and consultant (all payments to institution) for Arcus, AstraZeneca, Daiichi Sankyo, Deciphera Pharmaceuticals, Ellipses Pharma, Genentech/Roche, Greenwich LifeSciences, iTeos, Janssen, Eli Lilly, Loxo, Mersana, Novartis, Olema Pharmaceuticals, Orum Therapeutics, Pfizer, Relay Therapeutics, Seagen, Stemline Therapeutics, Verascity Science; and receives institutional research funding from, Abbvie, Acerta Pharma, Accutar Biotechnology, ADC Therapeutics, AKESOBIO Australia, Amgen, Aravive, Artios, Arvinas, AstraZeneca, AtlasMedx, BeiGene, Black Diamond, Bliss BioPharmaceuticals, Boehringer Ingelheim, Cascadian Therapeutics, Clovis, Compugen, Cullinan-Florentine, Curis, CytomX, Daiichi Sankyo, Dana Farber Cancer Inst, Dantari, Deciphera, Duality Biologics, eFFECTOR Therapeutics, Ellipses Pharma, Elucida Oncology, EMD Serono, FujiFilm, G1 Therapeutics, Genentech/Roche, H3 Biomedicine, Harpoon, Hutchinson MediPharma, Immunogen, Immunomedics, Incyte, Infinity Pharmaceuticals, InventisBio, Jacobio, Karyopharm, K-Group Beta, Eli Lilly, Loxo Oncology, Lycera, Mabspace Biosciences, Macrogenics, MedImmune, Mersana, Merus, Millennium, Molecular Templates, Novartis, Nucana, Olema, OncoMed, Onconova Therapeutics, Oncothyreon, ORIC Pharmaceuticals, Orinove, Pfizer, PharmaMar, Pieris Pharmaceuticals, Pionyr Immunotherapeutics, Plexxikon, Radius Health, Regeneron, Relay Therapeutics, Repertoire Immune Medicine, Rgenix, SeaGen, Sermonix Pharmaceuticals, Shattuck Labs, StemCentRx, Sutro, Syndax, Syros, Taiho, TapImmune, Tesaro, Tolmar, Torque Therapeutics, Treadwell Therapeutics, Verastem, Vincerx Pharma, Zenith Epigenetics, Zymeworks. P.L.R. currently is on Advisory Boards for I-Mab, Mersana Therapeutics, BAKX Therapeutics, Scenic Biotech, Qualigen, NeuroTrials; and a consultant for Roivant Sciences. I.K. is on the advisory boards and a consultant for Daiichi Sankyo, Macrogenics, Genentech/Roche, Seagen, AstraZeneca, Novartis and Merck; and receives institutional research funding and grants from Genentech/Roche, Pfizer and Macrogenics. M.S. is a former employee of Genentech and shareholder in F. Hoffmann-La Roche, Ltd. and a current employee and shareholder at Seagen. R.C. is a former employee of Genentech and shareholder in F. Hoffmann-La Roche, Ltd. and a current employee and shareholder at Gilead Sciences, Inc. M.S. is a former employee of Genentech and shareholder in F. Hoffmann-La Roche, Ltd.; is currently a consultant for Genentech; and is on the Scientific Advisory Boards for Novartis Institutes for BioMedical Research (NIBR), Olema Pharmaceuticals, ABL Bio.